Relevance of age at diagnosis to prevention of late-onset Group B streptococcal disease by maternal immunization

Pediatric Infectious Disease Journal

Volumn 34, Issue 5, 2015, Pages 538-539

  Edwards, Morven S ^a   Rench, Marcia A ^a   Baker, Carol J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

group B Streptococcus; late onset sepsis; maternal immunization; vaccine

Indexed keywords

GROUP B STREPTOCOCCAL GLYCOCONJUGATE VACCINE; STREPTOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD; ONSET AGE; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; THIRD TRIMESTER PREGNANCY; VACCINATION; INFANT, NEWBORN, DISEASES; MICROBIOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; STREPTOCOCCAL INFECTIONS; TEXAS; TRANSMISSION; VERTICAL TRANSMISSION;

FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TEXAS;

EID: 84930378900     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000640     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention. Active bacterial core surveillance report, Emerging infections program network, group B Streptococcus, 2013. Available at: http://www.cdc.gov/abcs/reports-findings/survreports/gbs13.pdf. Accessed January 20, 2015
2. Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012; 130: e8-e15
3. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and metaanalysis. Lancet. 2012; 379: 547-556
4. Lancefield R. Serologic differentiation of specific types of bovine hemolytic streptococci. J Exp Med. 1934; 59: 441-458
5. Baker CJ, Carey, VJ, Rench MA, et al. Maternal antibody at delivery protects neonates from early-onset group B streptococcal disease. J Infect Dis. 2014; 209; 781-788
6. Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease. A multistate, population-based analysis. Pediatr Infect Dis J. 2008; 27: 1057-1064
7. Berardi A, Rossi C, Lugli L, et al. Group B Streptococcus late-onset disease: 2003-2010. Pediatrics. 2013; 131: e361-e368
8. Kugelman A, Colin AA. Late preterm infants: near term but still in a critical developmental time period. Pediatrics. 2013; 132: 741-751
9. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003; 21: 3468-3472
10. Leroux-Roels G, Slobod K, Maes C, et al. Development of a trivalent vaccine to prevent group B Streptococcus infection. In: Abstracts of the XVIII Lancefield International Symposium, Palermo, Italy; September 2011: 139